IP Library › Granted Patent US 9,204,916
Granted Patent B2
US 9,204,916 · App. 13/282,811 · Granted Dec 8, 2015

Cryogenic balloon device with radiofrequency tip

Inventor: Jean-Pierre Lalonde (Candiac, CA)
Assignee: Medtronic CryoCath LP
A61B18/02A61B18/1492A61B2018/0022A61B2018/00255A61B2018/00357A61B2018/00613A61B2018/00642A61B2018/00702A61B2018/00714A61B2018/00791A61B2018/00863A61B2018/00898A61B2018/00994A61B2018/0212A61B2018/0262
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,204,916
App. No.
13/282,811
Granted
Dec 8, 2015
Kind
B2
Abstract

An intravascular ablation device, including a flexible elongate body; an expandable element positioned on the elongate body; a radiofrequency or electroporation treatment segment located distally of the expandable element; a cryogenic coolant source in fluid communication with an interior of the expandable element; and a radiofrequency or electroporation energy source in communication with the radiofrequency or electroporation treatment segment.

Claims (31)

1. A medical device, comprising:

an elongate catheter body including a proximal portion coupled to a handle and a distal portion;

a cryogenic treatment region coupled to the distal portion of the catheter body; and

at least one of a radiofrequency treatment region and an electroporation treatment region coupled to the distal portion of the catheter body at a location that is distal to the cryogenic treatment region and defining an outer surface of and a distal tip of the medical device.

2. The medical device of claim 1 , wherein the cryogenic treatment region includes an expandable element.

3. The medical device of claim 2 , wherein the at least one of a radiofrequency treatment region and an electroporation treatment region includes a substantially linear thermal segment.

4. The medical device of claim 1 , wherein the cryogenic treatment region is operable independently from the at least one of a radio frequency treatment region and an electroporation treatment region.

5. The medical device of claim 1 , further comprising a fluid flow path in fluid communication with the cryogenic treatment region.

6. The medical device of claim 5 , further comprising a cryogenic fluid source in fluid communication with the first fluid flow path.

7. The medical device of claim 6 , further comprising a radiofrequency signal source coupled to the at least one of a radiofrequency treatment region and an electroporation treatment region.

8. The medical device of claim 1 , further comprising a sensor coupled to at least one of the cryogenic treatment region or the at least one of a radiofrequency treatment region and an electroporation treatment region.

9. The medical device of claim 1 , wherein the at least one of a radiofrequency treatment region and an electroporation treatment region is deflectable independently of the cryogenic treatment region.

10. An intravascular ablation device, comprising:

a flexible elongate body including a proximal portion coupled to a handle and a distal portion;

an expandable element coupled to the distal portion of the elongate body;

a substantially linear, elongated radiofrequency thermal segment coupled to the distal portion of the elongate body and extending distally beyond the expandable element when the expandable element is fully expanded;

a cryogenic coolant source in fluid communication with an interior of the expandable element; and

a radiofrequency energy source in communication with the radiofrequency thermal segment.

11. The intravascular ablation device of claim 10 , wherein radiofrequency thermal segment includes an electrically-conductive distal tip.

12. A method of treating cardiac tissue, comprising:

positioning an expandable cryogenic treatment region proximate a pulmonary vein, the cryogenic treatment region being coupled to a distal portion of a medical device;

ablating tissue proximate the pulmonary vein with the expandable cryogenic treatment region;

positioning a radiofrequency treatment region proximate the pulmonary vein, the radiofrequency treatment region including an electrode coupled to distal portion of the medical device at a location distal to the cryogenic treatment region when the cryogenic treatment region is fully expanded; and

ablating tissue proximate the pulmonary vein with the radiofrequency treatment region.

13. The method of claim 12 , wherein positioning the expandable cryogenic treatment region includes expanding the expandable cryogenic treatment region in the pulmonary vein to substantially occlude the pulmonary vein.

14. The method of claim 13 , wherein ablating tissue proximate the pulmonary vein with the expandable cryogenic treatment region includes circulating a cryogenic fluid through the expandable cryogenic treatment region.

15. The method of claim 13 , wherein ablating tissue proximate the pulmonary vein with the expandable cryogenic treatment region includes creating a first ablative treatment pattern, and wherein ablating tissue proximate the pulmonary vein with the radiofrequency treatment region includes creating a second ablative treatment pattern.

16. The method of claim 15 , wherein the first ablative treatment pattern includes a substantially arcuate shape.

17. The method of claim 16 , wherein the second ablative treatment pattern includes a substantially focal shape.

18. The method of claim 17 , wherein the first and second ablative treatment patterns are substantially continuous.

19. The medical device of claim 9 , wherein the medical device further comprises a deflectable segment located between the at least one of a radiofrequency treatment region and an electroporation treatment region and the expandable cryogenic treatment region, the deflectable segment facilitating deflection of the at least one of a radiofrequency treatment region and an electroporation treatment region relative to the expandable cryogenic treatment region.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2011
From: LALONDE, JEAN-PIERRE
To: MEDTRONIC CRYOCATH LP
Reel/Frame 027132/0785 →
Continuity (1)
Related Publication 20130110098A1 · May 2, 2013